Two cold medicines for babies and toddlers have been taken off the shelves following health concerns.

Phoenix Stores has withdrawn Tynenol Infant Cold and Cough Drops and Tynenol Infant Cold Drops from each of its five outlets across the Island.

They were among a list of leading brands manufacturers voluntarily stopped selling in America after health groups reported deaths linked to unintentional overdoses.

George Grundmuller, chief executive of Phoenix Stores, said a recall was not being issued because the medicines are safe if taken in accordance with guidance on the label.

However, he said it was good practice to remove them from sale in line with the US.

"We had two items on sale for children which we have taken off the shelves," Mr. Grundmuller told The Royal Gazette.

"There's no suggestion that they are dangerous in any way. The product itself is safe to use but there could be issues when people overdose. That's been the concern. We have taken that very seriously and we made the decision."

The Consumer Healthcare Products Association announced on Thursday that manufacturers were voluntarily ending sales of over-the-counter oral cough and cold products aimed at children under age two.

It came a week before US Government advisers were to debate whether such medicines should be easily available.

Baltimore city officials filed a petition with the Food and Drug Administration arguing that oral cough and cold medicines for do not work in very young children and pose health risks.

Joshua Sharfstein, Baltimore's health commissioner and a paediatrician, said: "Paediatricians are taught these products don't work and may not be safe. Yet almost every parent uses them."

He said parents should try old-fashioned methods, like suctioning out infants' noses or using salt-water nose drops.